Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,056.9
-7.7 (-0.25%)

 

  • STI Straits Times Index
    3,056.9
    -7.7 (-0.25%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,545.9
    -9.3 (-0.60%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,807.0
    139.2 (0.56%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    6.9 (0.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,500.0
    176.7 (0.58%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,117.7
    7.8 (0.13%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,122.1M
  • Value: 984.9M
  • Rise: 143
  • Fall: 181
  • Unch: 430

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.076+0.016
GSS Energy0.077+0.005
ESR-REIT0.470-0.015
Sembcorp Marine0.082-0.001
YZJ Shipbldg SGD1.470-0.040
Lippo Malls Tr0.054+0.003
Singtel2.420+0.020
Genting Sing0.735-0.005
VCPlus0.026+0.002
OUE Com Reit0.445-

World Indices

World Indices
Name Last Change
Nasdaq 15,181.9 +20.4
HSI 24,791.9 +124.1
HSCEI 8,883.3 +77.5
Jakarta 6,116.7 +6.8
Nikkei 225 30,500.0 +176.7
SSE Comp 3,614.0 +6.9
Shanghai A 3,787.7 +7.3
Shanghai B 273.1 -1.8
KOSPI 3,140.5 +10.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ALCON AG ALCON AG
Updated on 16 Sep 2021 (End of trading day)
Last (USD): 86.370 Change: -0.880 High: 86.710 Remarks: -
Change (%): -1.01 Low: 86.110
Open 86.320 Yesterday's Close 87.25
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 592,980 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.06264 Trailing EPS (USD) e 0.36622 NAV (USD) b 38.1509
PE a - Trailing PE f 235.842 Price / NAV b 2.2639
Dividend (USD) d 0.104301 Cash In Hand (USD) g 2.7336 Issued & Paid-up Shares c 499,700,000
Dividend Yield (%) d 0.121 Price / Cash In Hand g 31.596 Treasury Shares h -
Market Cap (M) 43,159.089 Enterprise Value (M) 46,296.089
Piotroski F Score 4 Exchange Code ALC Par Value ( $ ) n.a.
52 Weeks Volatility (%) 27.88 Free Float (%) 100.0
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 07 Dec 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Apr 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ALCON AG NYSE 43,159.089 - 235.842 2.2639 0.121
Industry Medical Specialties NYSE 44,605.048 48.972 35.460 4.9580 0.586
Local Peer DANAHER CORP NYSE 231,303.600 65.899 65.898 5.8576 0.221
Local Peer ABBOTT LABORATORIES NYSE 225,928.181 50.509 35.602 6.6843 1.199
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 220,487.744 34.586 25.650 5.9827 0.158
Local Peer MEDTRONIC PLC NYSE 176,193.445 48.861 45.376 3.4222 1.848
Local Peer STRYKER CORP NYSE 104,119.977 65.116 49.986 7.5340 0.851
Local Peer EDWARDS LIFESCIENCES CORP NYSE 75,229.456 91.365 51.442 14.6552 -
Local Peer BECTON DICKINSON & CO NYSE 75,436.197 98.352 40.448 3.1259 1.230
Local Peer BOSTON SCIENTIFIC CORP NYSE 63,930.865 - 136.604 4.0102 -
Local Peer AGILENT TECHNOLOGIES INC NYSE 52,455.841 72.957 52.986 10.6057 0.420
Local Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 43,301.233 32.000 32.324 3.0550 2.159
Local Peer RESMED INC NYSE 41,690.989 87.862 87.862 14.4476 0.545
Local Peer BAXTER INTERNATIONAL INC NYSE 41,602.510 37.752 37.145 4.8979 1.159
Other Local Peers METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), NEVRO CORP (NYSE), CONMED CORP (NYSE), HAEMONETICS CORP (NYSE), GLAUKOS CORPORATION (NYSE), BUTTERFLY NETWORK INC (NYSE), AVANOS MEDICAL INC (NYSE), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INVACARE CORP (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 123,037.884 116.008 75.828 11.3530 -
Global Peer IDEXX LABORATORIES INC NASDAQ 56,443.606 97.019 77.549 75.5139 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 57,543.285 32.403 82.387 17.0025 -
Global Peer DEXCOM INC NASDAQ 54,675.706 110.769 103.045 27.3706 -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 27,769.969 38.166 68.843 8.5984 -
Global Peer INSULET CORPORATION NASDAQ 19,828.796 2,916.034 - 43.1906 -
Global Peer HOLOGIC INC NASDAQ 19,556.522 17.536 9.597 5.0441 -
Global Peer ABIOMED INC NASDAQ 16,240.212 72.011 105.175 12.4206 -
Global Peer MASIMO CORPORATION NASDAQ 15,083.388 62.768 67.429 10.8417 -
Global Peer DENTSPLY SIRONA INC NASDAQ 13,596.058 - 36.916 2.6796 0.643
Other Global Peers NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), COCHLEAR LTD (ASX), MICROPORT (HKEx), TANDEM DIABETES CARE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), WEIGAO GROUP (HKEx), SOTERA HEALTH CO (NASDAQ), ANGELALIGN (HKEx), STAAR SURGICAL CO (NASDAQ), Top Glove (SGX), TOPGLOV (Bursa), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), HARTA (Bursa), INMODE LTD (NASDAQ), LIVANOVA PLC (NASDAQ), NEOGEN CORP (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), INARI MEDICAL INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), CAREDX INC (NASDAQ), ATRICURE INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), VENUS MEDTECH-B (HKEx), CARDIOFLOW-B (HKEx), LIFETECH SCI (HKEx), SILK ROAD MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), PEIJIA-B (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ZYLOXTB-B (HKEx), KANGJI MEDICAL (HKEx), SUPERMX (Bursa), INOVIO PHARMACEUTICALS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), AK MEDICAL (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), PULMONX CORPORATION (NASDAQ), NANOSONICS LIMITED (ASX), ALPHATEC HLDGS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), SIGHT SCIENCES INC (NASDAQ), ATRION CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), INOGEN INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), CERUS CORP (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), DERMTECH INC (NASDAQ), 908 DEVICES INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CIRC (HKEx), CUTERA INC (NASDAQ), MODERN DENTAL (HKEx), TRANSMEDICS GROUP INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), EARGO INC (NASDAQ), BIOVENTUS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), INTERCURE LTD (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SI BONE INC (NASDAQ), SISRAM MED (HKEx), CHUNLI MEDICAL (HKEx), NYXOAH SA (NASDAQ), AXOGEN INC (NASDAQ), KDL MEDICAL (HKEx), PAVMED INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), ACOTEC-B (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), HEARTCARE-B (HKEx), FLUIDIGM CORP DEL (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), SOLITON INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), BASECARE-B (HKEx), NEUROPACE INC (NASDAQ), STEREOTAXIS INC (NYSE American), ZYNEX INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), ACUTUS MEDICAL INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), SIENTRA INC (NASDAQ), ONCOCYTE CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), YESTAR HEALTH (HKEx), CONFORMIS INC (NASDAQ), CVRX INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), ACCURAY INCORPORATED (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), PROFOUND MED CORP (NASDAQ), QUOTIENT LTD (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), AROA BIOSURGERY LTD (ASX), PW MEDTECH (HKEx), CLARITY PHARMACEUTICALS LTD (ASX), MYMD PHARMACEUTICALS INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), DARIOHEALTH CORP (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), UGHealthcare (SGX), SURGALIGN HOLDINGS INC (NASDAQ), INTRICOM CORP (NASDAQ), Medtecs Intl (SGX), TELA BIO INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), NEURONETICS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), NEMAURA MEDICAL INC (NASDAQ), SOMNOMED LIMITED (ASX), REPRO MEDSYSTEMS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), IMPEDIMED LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), FONAR CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), IRIDEX CORP (NASDAQ), ALPHA PRO TECH (NYSE American), CYCLOPHARM LIMITED (ASX), OPTISCAN IMAGING (ASX), ELECTROMED INC (NYSE American), MEDAVAIL HOLDINGS INC (NASDAQ), KELFRED (HKEx), CRYO-CELL INTERNATIONAL INC (NASDAQ), BIOLASE INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), MICRO-X LTD (ASX), CHECK-CAP LTD (NASDAQ), NEPHROS INC (NASDAQ), LENSAR INC (NASDAQ), SDI LTD (ASX), CELSION CORPORATION (NASDAQ), VINCENT MED (HKEx), VOLITIONRX LIMITED (NYSE American), HANCOCK JAFFE LABORATORIES INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), AVINGER INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), RGTBHD (Bursa), NEUROMETRIX INC (NASDAQ), APPLIED UV INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), YUNNAN ENERGY (HKEx), IMAGION BIOSYSTEMS LIMITED (ASX), DIMERIX LTD (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), BIOMERICA INC (NASDAQ), COMPUMEDICS (ASX), ADVENTA (Bursa), NEOVASC INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DAXOR CORP (NYSE American), LKL (Bursa), CARDIEX LTD (ASX), RESPIRI LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), KEWAUNEE SCIENTIFIC CORP (NASDAQ), INSPIREMD INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), TENAX THERAPEUTICS INC (NASDAQ), Yunnan Energy (SGX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), Biolidics (SGX), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), DYNATRONICS CORP (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), RA MEDICAL SYSTEMS INC (NYSE American), OSPREY MEDICAL INC NPV DFD 23/09/21(EX-SPLIT) (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), CYANOTECH CORP (NASDAQ), OVENTUS MEDICAL LTD (ASX), NUWELLIS INC (NASDAQ), LIFE HEALTHCARE (HKEx), USCOM LTD (ASX), METALICITY LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+2.570
+3.07 %
10 Days -+1.810
+2.14 %
20 Days -+5.660
+7.01 %
Medium Term Return 3 Months -+16.130
+22.96 %
6 Months -+18.220
+26.74 %
1 Year -+27.530
+46.79 %
Long Term Return 2 Years -+26.600
+44.50 %
Annualised Return Annualised --
+20.21 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 55.760 - 87.490 Change From 1 Year Low +30.610 % Change From 1 Year Low (%) +54.90
Change From 1 Year High -1.120 % Change From 1 Year High (%) -1.28
2 Years Range 39.370 - 87.490 Change From 2 Years Low +47.000 % Change From 2 Years Low (%) +119.38
Change From 2 Years High -1.120 % Change From 2 Years High (%) -1.28
5 Years Range 39.370 - 87.490 Change From 5 Years Low +47.000 % Change From 5 Years Low (%) +119.38
Change From 5 Years High -1.120 % Change From 5 Years High (%) -1.28
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.

Historical Price Data

Date Open High Low Close Volume VWAP
16 Sep 2021 86.320 86.710 86.110 86.370 592,980 -
15 Sep 2021 87.010 87.490 86.570 87.250 616,265 -
14 Sep 2021 85.520 86.650 85.270 86.440 1,171,532 -
13 Sep 2021 84.740 84.800 83.575 83.950 1,485,660 -
10 Sep 2021 84.020 84.350 83.780 83.800 588,517 -
09 Sep 2021 84.360 84.790 83.550 83.570 528,334 -
08 Sep 2021 83.400 84.160 83.335 83.950 570,399 -
07 Sep 2021 85.410 85.533 84.710 84.940 743,513 -
03 Sep 2021 84.170 84.710 84.050 84.560 441,966 -
02 Sep 2021 83.740 84.490 83.510 84.490 745,283 -
01 Sep 2021 83.000 83.600 82.830 83.170 690,357 -
31 Aug 2021 82.890 82.950 82.030 82.470 502,557 -
30 Aug 2021 82.170 82.560 81.960 81.990 474,328 -
27 Aug 2021 81.630 82.220 81.490 82.040 1,037,624 -
26 Aug 2021 81.230 81.485 80.790 81.230 820,051 -
25 Aug 2021 81.000 81.060 80.300 80.820 1,071,976 -
24 Aug 2021 81.650 81.830 81.090 81.210 1,035,503 -
23 Aug 2021 81.290 81.530 80.610 80.690 897,355 -
20 Aug 2021 80.500 81.200 80.340 80.710 1,125,037 -
19 Aug 2021 80.040 80.980 79.260 80.740 1,719,272 -
18 Aug 2021 80.290 80.630 78.700 80.060 4,114,637 -
17 Aug 2021 70.445 71.500 70.080 71.360 1,130,728 -
Summary
Current 2 Weeks
(02 Sep 2021 to 16 Sep 2021)
83.740 87.490 83.335 86.370 7,484,449 -
Previous 2 Weeks
(19 Aug 2021 to 01 Sep 2021)
80.040 87.490 79.260 83.170 9,374,060 -
4 Weeks from
(22 Jul 2021 to 18 Aug 2021)
70.150 87.490 69.770 80.060 18,436,185 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.